0001140361-24-037346.txt : 20240814
0001140361-24-037346.hdr.sgml : 20240814
20240814164138
ACCESSION NUMBER: 0001140361-24-037346
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240812
FILED AS OF DATE: 20240814
DATE AS OF CHANGE: 20240814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GKCC, LLC
CENTRAL INDEX KEY: 0001977769
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 241208926
BUSINESS ADDRESS:
STREET 1: 501 SILVERSIDE ROAD
STREET 2: SUITE 87AVA
CITY: WILMINGTON
STATE: DE
ZIP: 19809
BUSINESS PHONE: (302) 992-8882
MAIL ADDRESS:
STREET 1: 501 SILVERSIDE ROAD
STREET 2: SUITE 87AVA
CITY: WILMINGTON
STATE: DE
ZIP: 19809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chudnovsky Yekaterina
CENTRAL INDEX KEY: 0001979324
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 241208927
MAIL ADDRESS:
STREET 1: C/O ELICIO THERAPEUTICS, INC.
STREET 2: 451 D STREET, 5TH FLOOR, SUITE 501
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elicio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (857) 209-0050
MAIL ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Angion Biomedica Corp.
DATE OF NAME CHANGE: 20140228
4
1
form4.xml
FORM 4
X0508
4
2024-08-12
0001601485
Elicio Therapeutics, Inc.
ELTX
0001979324
Chudnovsky Yekaterina
C/O ELICIO THERAPEUTICS, INC.
451 D STREET, 5TH FLOOR
BOSTON
MA
02210
true
true
0001977769
GKCC, LLC
501 SILVERSIDE ROAD
SUITE 87AVA
WILMINGTON
DE
19809
true
false
Convertible Note (convertible into Common Stock)
5.81
2024-08-12
4
P
0
3442341
5.81
A
Common Stock
3442341
3442341
I
Held by GKCC, LLC
On August 12, 2024, GKCC, LLC (the "Purchaser") purchased from the Issuer a convertible note with an aggregate principal amount of $20,000,000 (the "Convertible Note"). The Convertible Note is convertible into shares of common stock of the Issuer at a conversion price of $5.81 per share, subject to adjustment in certain circumstances. Therefore, the Convertible Note is initially convertible into approximately 3,442,341 shares of common stock of the Issuer.
The Convertible Note will mature on February 15, 2026, unless earlier converted in accordance with the terms of the Convertible Note. Interest on the Convertible Note is payable in cash and will accrue and be payable quarterly on the principal amount equal to 3% per annum.
Yekaterina (Katie) Chudnovsky is the sole member and manager of the Purchaser and may be deemed to beneficially own the shares held by the Purchaser.
/s/ Yekaterina Chudnovsky
2024-08-14
/s/ Yekaterina Chudnovsky, Manager GKCC, LLC
2024-08-14